Literature DB >> 1641086

Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model.

S A Menzies1, J T Hoff, A L Betz.   

Abstract

Middle cerebral artery occlusion (MCAO) in rats produces an infarct of varying size. We examined three factors that may influence this variability: animal weight, vascular anatomy, and extent of occlusion in rats undergoing MCAO. We also developed a four-point neurological evaluation scale and validated its usefulness by comparing it with a four-grade pathological determination of the size of the infarct. Of 82 animals subjected to a standard MCAO, 34 developed small cortical infarcts (pathological grades I-II; infarct size less than 25 mm2, 6-17% of the ipsilateral cortex surface area), and 48 large infarcts (pathological grades III-IV, infarct size greater than 25 mm2, 20-56% of surface area). We were able to predict the size of infarction from the neurological evaluation in 83% of the animals, and this accuracy reached 91% when grades I and II and III and IV were considered together (P less than 0.001). In 41 animals subjected to a more extensive vascular occlusion, 89% exhibited large infarcts. Four vascular patterns were identified but none played a significant role in the incidence or size of the cortical stroke. However, rats weighing less than 300 g showed a smaller lesion size than did rats greater than 300 g. Our proposed new MCAO technique appears useful in reproducing large-sized infarcts of the frontoparietal cortex.

Entities:  

Mesh:

Year:  1992        PMID: 1641086     DOI: 10.1227/00006123-199207000-00014

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  88 in total

1.  Delayed and multiple hyperbaric oxygen treatments expand therapeutic window in rat focal cerebral ischemic model.

Authors:  Dali Yin; John H Zhang
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke.

Authors:  Yi-Je Chen; Girija Raman; Silke Bodendiek; Martha E O'Donnell; Heike Wulff
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-13       Impact factor: 6.200

3.  17β-estradiol attenuates breakdown of blood-brain barrier and hemorrhagic transformation induced by tissue plasminogen activator in cerebral ischemia.

Authors:  Mingchang Li; Zhan Zhang; Weiyun Sun; Raymond C Koehler; Judy Huang
Journal:  Neurobiol Dis       Date:  2011-07-18       Impact factor: 5.996

4.  Neuroprotective effect of resveratrol on ischemia/reperfusion injury in rats through TRPC6/CREB pathways.

Authors:  Yun Lin; Fang Chen; Jiancheng Zhang; Tingting Wang; Xin Wei; Jing Wu; Yinglu Feng; Zhongliang Dai; Qingping Wu
Journal:  J Mol Neurosci       Date:  2013-02-23       Impact factor: 3.444

5.  Effects of intravenous dimethyl sulfoxide on ischemia evolution in a rat permanent occlusion model.

Authors:  Juergen Bardutzky; Xianjun Meng; James Bouley; Timothy Q Duong; Rajiv Ratan; Marc Fisher
Journal:  J Cereb Blood Flow Metab       Date:  2005-08       Impact factor: 6.200

6.  Overexpression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia.

Authors:  Lijun Xu; Ludmila A Voloboueva; YiBing Ouyang; John F Emery; Rona G Giffard
Journal:  J Cereb Blood Flow Metab       Date:  2008-11-05       Impact factor: 6.200

7.  Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection.

Authors:  Aysan Durukan; Turgut Tatlisumak
Journal:  Exp Transl Stroke Med       Date:  2010-01-21

8.  G-CSF, rt-PA and combination therapy after experimental thromboembolic stroke.

Authors:  Rainer Kollmar; Nils Henninger; Christian Urbanek; Stefan Schwab
Journal:  Exp Transl Stroke Med       Date:  2010-04-14

9.  Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway.

Authors:  Aida Maddahi; Lars Edvinsson
Journal:  J Neuroinflammation       Date:  2010-02-26       Impact factor: 8.322

10.  Enhanced cerebrovascular expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 via the MEK/ERK pathway during cerebral ischemia in the rat.

Authors:  Aida Maddahi; Qingwen Chen; Lars Edvinsson
Journal:  BMC Neurosci       Date:  2009-06-04       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.